Outcome of patients admitted with acute coronary syndrome on palliative treatment: Insights from the nationwide AMIS Plus registry 1997-2014

BMJ Open

Volumn 5, Issue 3, 2015, Pages

  Erne, Paul ^a,b,c   Radovanovic, Dragana ^a   Seifert, Burkhardt ^a   Bertel, Osmund ^d   Urban, Philip ^e  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Klinik St Anna   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d KLINIK IM PARK   (Switzerland)

^e LA TOUR HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICOAGULANT AGENT; FIBRINOGEN RECEPTOR; HEPARIN; PURINERGIC P2Y RECEPTOR ANTAGONIST;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY REPERFUSION; FEMALE; FOLLOW UP; HEART REINFARCTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REGISTER; VERY ELDERLY; AGE; COMPLICATION; FIBRINOLYTIC THERAPY; HEART FAILURE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PATHOLOGY; PREVALENCE; PROCEDURES; SHOCK, CARDIOGENIC; SWITZERLAND; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; ANTICOAGULANTS; COHORT STUDIES; FEMALE; HEART FAILURE; HEPARIN; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PALLIATIVE CARE; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PREVALENCE; PURINERGIC P2Y RECEPTOR ANTAGONISTS; REGISTRIES; SHOCK, CARDIOGENIC; SWITZERLAND; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84926637992     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006218     Document Type: Article

References (12)

1. Radovanovic D, Erne P. AMIS Plus: Swiss registry of acute coronary syndrome. Heart 2010;96:917-21.
2. Radovanovic D, Nallamothu BK, Seifert B, et al. Temporal trends in treatment of ST-elevation myocardial infarction among men and women in Switzerland between 1997 and 2011. Eur Heart J Acute Cardiovasc Care 2012;1:183-91.
3. Witassek F, Schwenkglenks M, Erne P, et al. Impact of body mass index on mortality in Swiss hospital patients with ST-elevation myocardial infarction: does an obesity paradox exist? Swiss Med Wkly 2014;144:w13986.
4. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
5. Radovanovic D, Seifert B, Urban P, et al. Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012. Heart 2014;100:288-94.
6. Thygesen K, Alpert JP, White HD, et al. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-38.
7. Urban P, Radovanovic D, Erne P, et al. Impact of changing definitions for myocardial infarction: a report from the AMIS registry. Am J Med 2008;121:1065-71.
8. Schoenenberger AW, Radovanovic D, Stauffer JC, et al. Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes: a cohort study. J Am Geriatr Soc 2008;56:510-16.
9. Jaarsma T, Beattie JM, Ryder M, et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2009;11:433-43.
10. Jao GT, Knovich MA, Savage RW, et al. ST-elevation myocardial infarction and myelodysplastic syndrome with acute myeloid leukemia transformation. Tex Heart Inst J 2014;41:234-7.
11. Vastbinder MB, Drost H, Muller EW. [Acute coronary syndrome after chemotherapy]. Ned Tijdschr Geneeskd 2014;158:A6940.
12. Fenning S, Woolcock R, Haga K, et al. Identifying acute coronary syndrome patients approaching end-of-life. PLoS ONE 2012;7:e35536.